On the last day, the KRM Ayurveda IPO was subscribed 74.27 times overall, with the retail quota at 54.21 times, the QIB quota at 63.31 times, and the NII quota at 135.37 times, respectively.
Details About KRM Ayurveda IPO
KRM Ayurveda got approval from SEBI for an IPO of ₹77.49 crores via an IPO that comprises a fresh issue of ₹77.49 crores with a face value of ₹10 each.
Moreover, the company has set up a price band between ₹128 to ₹135 per share.
In this IPO, a total of 2,000 shares were available in 2 lot sizes for the minimum Retail category and for the maximum retail category. In S-HNI (Min) total of 3,000 shares is in a 3-lot size. In S-HNI (Max), a total of 7,000 shares are in a 7-lot size. While in a B-HNI Minimum, a total of 8,000 shares are in an 8-lot size.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum & Maximum investment of ₹2,70,000.
- Small HNI (Min): Minimum investment of ₹4,05,000.
- Small HNI (Max): Maximum investment of ₹9,45,000
- B-HNI (Min): Minimum investment of ₹10,80,000
Subscription duration of the KRM Ayurveda IPO
The KRM Ayurveda IPO opened on January 21, 2026, and closed on January 23, 2026.
The allotment of KRM Ayurveda was finalized on January 27, 2026, and the IPO listing is scheduled for January 29, 2026.
About KRM Ayurveda IPO
Founded on 3 September 2019, KRM Ayurveda is one of the leading companies of Ayurvedic products. They manufacture various Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items.
The company has good services for the patient, including In-Patient & Out-Patient Care, Panchakarma Therapies, Specialized Clinics, Medicinal Sales, Diet & Lifestyle Counseling. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. The company has many hospitals and clinics across India, not only in India, but it also provides telemedicine services and sales abroad.
KRM Ayurveda IPO Company Financial Report
The company reported revenue of ₹76.95 crores in 2025 against ₹67.57 crores in 2024. The company rep
